Podcast

Jessica Isom, MD, MPH, is a board-certified community psychiatrist and faculty leader in the Yale Department of Psychiatry’s Social Justice and Health Equity Curriculum. She primarily works in Boston as an attending psychiatrist at Codman Square Health Center where she is leading a grant effort to infuse antiracism in OUD services. She is a nationally recognized expert on racial equity and justice in psychiatry with a focus on workforce development and organizational transformation. Her professional interests include working toward eradicating racial and ethnic mental health disparities, mitigating the impact of implicit racial bias on clinical care, and the use of a community-centered population health approach in psychiatric practice. She serves on multiple advisory boards and is a consultant, curriculum developer, and presenter to a variety of organizations including Fortune 500 companies and medical societies through her company, Vision for Equity LLC.

Amanda J. Calhoun, MD, MPH, is an Adult/Child Psychiatry Resident at Yale Child Study Center/Yale School of Medicine and is concurrently pursuing a PhD in Yale’s Graduate School of Arts & Sciences.  Dr. Calhoun graduated from Yale University with a BA in Spanish and received her MD/MPH from Saint Louis University School of Medicine, in St. Louis, Missouri, where she grew up.  Dr. Calhoun’s research, which focuses on the mental health effects of anti-Black racism on children, has been funded by multiple national awards.  Dr. Calhoun also specializes in the effects of medical racism and writes for both academic journals as well as general press and has published in New England Journal of Medicine, TIME magazine, HuffPost, STAT News, Washington Post, BET News, and many others. Dr. Calhoun is also a public speaker, and a consultant and has made multiple national news appearances, most recently on CBS News discussing the rising rates of Black youth suicide.

Twitter handle: @AmandaJoyMD

Professional Instagram: amandajoymd

Joia A. Crear-Perry, MD, FACOG, is a physician, policy expert, thought leader, and advocate for transformational justice. As the founder and president of the National Birth Equity Collaborative (NBEC), she identifies and challenges racism as a root cause of health inequities.

She is a highly sought-after trainer and speaker who has been featured in national and international publications including Essence and Ms. Magazine. In 2020, Dr. Crear-Perry was honored by USA Today in its “Women of the Century” series and featured on ABC Nightline’s “Hear Her Voice”.

Dr. Crear-Perry has twice addressed the United Nations’ Office of the High Commissioner for Human Rights to elevate the cause of gender diversity and urge a human rights framework toward addressing maternal mortality. A proud recipient of both the Congressional Black Caucus Healthcare Heroes award and the Maternal Health Task Force at Harvard University Global Visionary Award for Commitment to Advancing Women’s Health, Dr. Crear-Perry’s most notable efforts include the removal of race as a risk factor for illnesses including premature birth.

Previously, she served as the Executive Director of the Birthing Project, Director of Women?s and Children’s Services at Jefferson Community Healthcare Center, and as the Director of Clinical Services for the City of New Orleans Health Department. In that role, she was responsible for four facilities that provided health care for the homeless, pediatric, WIC, and gynecologic services within the New Orleans clinical service area. Dr. Crear-Perry has been celebrated for her work improving the availability and utilization of affordable health care for New Orleans citizens post the Hurricane Katrina disaster of 2005.

Dr. Crear-Perry testified before the House Energy and Commerce Committee as the Democratic witness in support of the only Maternal Health Bill signed into law under the Trump administration. She has received funding from the Robert Wood Johnson Foundation (RWJF) to work with the American College of Obstetrics and Gynecology (ACOG) and develop a Standard for Respectful Maternity Care. She also serves on the National Quality Forum Maternal Mortality and Morbidity Committee and the Joint Commission Perinatal Safety Project Technical Advisory Panel.

Dr. Crear-Perry currently serves as a Principal at Health Equity Cypher and on the Board of Trustees for Black Mamas Matter Alliance, Community Catalyst, National Clinical Training Center for Family Planning, and the UCSF PTBi.

After completing undergraduate studies at Princeton University and Xavier University, Dr. Crear-Perry received her MD from Louisiana State University and completed her residency in Obstetrics and Gynecology at Tulane University’s School of Medicine. She was also recognized as a Fellow of the American College of Obstetrics and Gynecology.

She is married to Dr. Andre Perry and has three children: Jade, Carlos, and Robeson. Her love is her family; health equity is her passion; maternal and child health are her callings.

Sorana Segal-Maurer, MD is Director of Infectious Diseases at NewYork-Presbyterian Queens in Flushing, NY and Professor of Clinical Medicine at Weill Cornell Medicine in New York, NY. She has published extensively, as author of peer-reviewed articles on HIV treatment adherence, diagnosis, and treatment of metabolic and morphologic changes in HIV infected patients, and is an author of the section, “Nutritional Metabolism and Support in the Setting of HIV Infection“, in the Adult Nutrition Support Core Curriculum textbook. She is actively involved in HIV research, serving as principal investigator or co-investigator in phase II, III, IV clinical trials as well as investigator-initiated trials. Currently, she is the lead author on the 2022 NEJM publication of the CAPELLA trial where the use of lenacapavir was evaluated in a cohort of heavily treated persons living with HIV. She has been in clinical practice for nearly 30 years.

Dr. Segal-Maurer is board-certified in infectious diseases and is a Diplomate of the American Board of Medical Examiners. She received her medical degree from Icahn School of Medicine in New York, NY and completed an internship, residency, and infectious diseases fellowship at Albert Einstein College of Medicine/Montefiore Medical Center in Bronx, NY.

In response to the HIV pandemic, Dr. Wohl has focused his career on optimizing the treatment of HIV infection, including identifying the most effective therapeutic approaches and minimizing the adverse effects of therapy. Cognizant that HIV disproportionately affects the most vulnerable, he has worked to improve HIV care and prevention for often marginalized individuals such as the incarcerated, men who have sex with men, and those living in poverty.

Dr. Wohl is active within the U.S. AIDS Clinical Trials Group (ACTG) and HIV Prevention Trials Network (HPTN), and served two terms as a member of the U.S. Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines and was recently invited to serve on the DHHS Panel on Opportunistic Infection Guidelines.

As part of the response to the 2013-2016 Ebola outbreak in West Africa, Dr. Wohl led UNC clinical research efforts to test interventions for Ebola Virus Disease in Liberia and now is a principal investigator of a clinical cohort that longitudinally follows Ebola survivors, as well as a study to determine the natural history of Lassa fever.

In addition to his research and administrative activities, Dr. Wohl maintains a large HIV continuity clinic at UNC.

Dr. Richard Furie, Chief of the Division of Rheumatology at Northwell Health, is a rheumatologist whose activities for the last several decades have focused on patient care, physician education, and clinical research in the area of anti-rheumatic drug development. He directs The Program in Novel Therapeutics, the Health System’s clinical research program in musculoskeletal disease. He also directs the Hospital?s SLE and Autoimmune Disease Treatment Center, which has become internationally recognized for its role in the development of new therapies for SLE. Regarded as one of the senior rheumatologists in the New York metropolitan area, Dr. Furie has served as a volunteer for the local chapters of the Arthritis Foundation and the Lupus Alliance, the Lupus Foundation of America, the SLE Foundation, the Lupus Research Alliance, and Lupus Therapeutics. For 20 years he served on many committees of the American College of Rheumatology and was named a Master of the College in 2018. Although often featured as a speaker at national and international conferences, Dr. Furie’s favorite educational venue is at home with his colleagues and trainees.

Allan Gibofsky, MD, JD, MACR, FACP, FCLM, serves as Professor of Medicine in the Department of Healthcare Policy and Research at Weill Cornell Medicine. Dr Gibofsky is an attending physician and rheumatologist at the Hospital for Special Surgery, where he is Co- Director of the Clinic for Inflammatory Arthritis. He received his undergraduate degree from Brooklyn College of the City University of New York, his medical degree from Weill Medical College of Cornell University, and his law degree from Fordham University School of Law. He did his internship in pathology, followed by a residency in medicine at New York Hospital. He completed a fellowship in rheumatology/immunology jointly at Hospital for Special Surgery and at The Rockefeller University. Dr Gibofsky has authored or co-authored numerous papers and textbook chapters, primarily on rheumatic diseases and legal aspects of medical practice. He is known for his work on mechanisms of host-microbe interactions in rheumatology, and, in particular, for his basic and clinical studies on rheumatic fever.

Currently Secretary-Treasurer of The New York Rheumatism Association, Dr Gibofsky is past Chair of the Medical & Scientific Committee of the New York Chapter of The Arthritis Foundation and is a recipient of its Physicians’ Leadership Award. He also served as a member of the local and national Arthritis Foundation Board of Trustees and was Chair for Professional Education. Dr Gibofsky has participated in numerous professional and public education programs, nationally and internationally. He served as President of The American College of Rheumatology and was recently named a Master. Dr Gibofsky is a Jonas Salk Scholar of the City University and an Alumnus of the Year of Brooklyn College. He is past President of the American College of Legal Medicine and is past Chair of the American Board of Legal Medicine. Dr Gibofsky is past Chair of the Arthritis Advisory Committee of the Food and Drug Administration and continues as a special consultant to that committee.

Dr. Martinez cares for patients with liver disease and addiction disorders, including opiate dependency, viral hepatitis, alcoholic and fatty liver disease, at Erie County Medical Center where he is the Medical Director of Hepatology. His clinic “La Bodega” has been recognized both nationally and internationally as a novel co- localized model for the management of viral hepatitis and addiction disorders, and has been awarded a New York State World AIDS Day Commissioner’s Special Recognition Award. The clinic has also been designated as a center for drug user health in New York State. Dr. Martinez has lectured around the world on hepatitis C management among people with substance use disorders, most recently at the International Hepatology Exchange in Amsterdam. His team’s work has been presented at the annual liver meeting of the American Association for the Study of Liver Diseases (AASLD); the annual conference of the International Network On Viral Hepatitis in Substance Users, and at the International Liver Congress.

His research involves improving hepatitis C treatment in populations disproportionately affected by HCV, particularly people who inject drugs. He has been a primary and co-investigator on numerous clinical trials related to new therapeutic agents for hepatitis C and fatty liver disease.

A fierce advocate, he has worked to eliminate hepatitis C treatment restrictions throughout the United States and in Europe.

Dr. Martinez is a member of the AASLD where he was recently elected to the HCV special interest group steering committee, the European Association for the Study of the Liver, and the American Society of Addiction Medicine.

Dr. Lim is a Professor of Medicine and Vice-Chief of the Section of Digestive Diseases at Yale University, where he serves as Director of Clinical Hepatology and Associate Chief of Yale-New Haven Health System (YNHHS) Digestive Health. He is a graduate of the Feinberg School of Medicine at Northwestern University (Chicago, Illinois, USA), and completed training in Internal Medicine at Yale University (New Haven, Connecticut, USA), and Gastroenterology and Hepatology at Stanford University (Palo Alto, California, USA). In his role at the Yale Liver Center, he conducts patient-oriented research evaluating clinical outcomes in chronic liver disease and runs an active clinical trials program examining novel investigational agents for viral hepatitis and NASH. He has held numerous leadership roles for the AASLD, AGA, and the ACG, and serves as Chair of the EPIC Gastroenterology Specialty Steering Board.

Nancy Reau, MD, is Professor of Internal Medicine, Richard B. Capps Chair of Hepatology, Associate Director of Solid Organ Transplantation, and Section Chief of Hepatology at Rush University Medical Center in Chicago, IL. She received her medical degree from The Ohio State University College of Medicine in Columbus, where she completed a residency and fellowship in gastroenterology/hepatology followed by a second fellowship in advanced transplant hepatology at Johns Hopkins Hospital in Baltimore, MD. Her primary research interests focus on viral hepatitis – from both drug development and a clinical perspective – liver transplantation, and complications of chronic liver disease.

Prof. Reau has been an invited lecturer at numerous presentations focused on viral hepatitis, fatty liver disease, cirrhosis, and liver transplantation. Prof. Reau is a fellow of the American Gastroenterological Association and American Association for the Study of Liver Diseases (AASLD). Additionally, she is the current editor in chief of CLD (Clinical Liver Disease) and was an author of the AASLD/IDSA hepatitis C guidance document. She was the committee chair of the AASLD public policy committee and a member of the AASLD practice guideline committee for four years.

Prof. Reau has authored or coauthored more than 100 peer-reviewed articles that have been published in journals such as Hepatology, Hepatitis Research and Treatment, and Clinics in Liver Disease. She is Co-chair of the National ALF Medical Advisory Committee and sits on multiple advisory boards. She is currently a member of the steering committee for the hepatitis C special interest group (SIG) for the American Association for the Study of Liver Diseases (AASLD) and a member of the ACG training committee.

Dr. Hines is currently the Medical Director of Diversity, Inclusion and the Center for Health Equity for Wellstar Health System in Marietta, Georgia. He is also the Chief of the Division of Gynecologic Oncology for Wellstar Medical Group.

Jeffrey Freeman Hines is a native of New York. He attended Brown University in Providence, RI, as part of the combined Seven-Year Medical Education Program. He received his undergraduate bachelor of science degree from Brown in Biology, magna cum laude, in May 1983. Jeffrey received his medical degree from The Warren Alpert Medical School of Brown University School of Medicine in May 1986.

Dr. Hines completed a four-year residency program in Obstetrics and Gynecology at Fitzsimons Army Medical Center, Aurora, CO, from July 1986-June 1990. In September 1990, Dr. Hines was deployed with the First Cavalry Division as a Battalion Surgeon during Operation Desert Shield and Operation Desert Storm. Dr. Hines completed a three-year fellowship in Gynecologic Oncology at Georgetown University Medical Center in June 1995.

Dr. Hines is a Diplomate of the American Board of Obstetrics and Gynecology with special competence in Gynecologic Oncology, a Fellow of the American College of Obstetricians and Gynecologists, and a Full Member of the Society of Gynecologic Oncologists. He is also a member of the American Society of Clinical Oncology, and the National Medical Association. Dr. Hines serves as a manuscript referee to several peer review medical journals to include Gynecologic Oncology, The Journal of the National Medical Association, and Obstetrics and Gynecology. Dr. Hines is critically involved in collaborative clinical oncology research. He is an institutional investigator for NRG Oncology of the National Cancer Institute.

Dr. Hines has extensive research interests, background, and is published in the field of papillomaviruses, cervical cancer vaccines, clinical cancer trials, disparities in health care, undergraduate student education, health equity, and racism in medicine. He has presented his work at national and international meetings. He has been an invited lecturer to national venues as well as to India and Mexico in the field of papillomaviruses. Dr. Hines also has expertise in all aspects of the treatment of women with cervical cancer, vaginal cancer, vulvar cancer, endometrial cancer, and ovarian cancer. He has expertise in the da Vinci robotic system. He is also actively involved in providing cancer health education lectures to at-risk groups.

Dr. Hines is the recipient of numerous local and national teaching awards for excellence in undergraduate and graduate medical education. He was the recipient of two awards by the Society of Gynecologic Oncologists and the Gynecologic Cancer Foundation for his research in papillomaviruses in 1994. Dr. Hines is also the recipient of the U.S. Army Meritorious Service Medal. Dr. Hines was listed as one of Atlanta’s Top Doctors in the 2005 – 2021 editions of Atlanta Magazine. In November 2005, Georgia Governor Sonny Perdue nominated Dr. Hines to serve on the Governor’s Task Force for the Elimination of Cervical Cancer for the State of Georgia.

Dr. Hines enjoys collecting African-American art and running marathons.